4//SEC Filing
Levine Mitchell S 4
Accession 0001493152-21-005103
CIK 0001642380other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:32 PM ET
Size
5.6 KB
Accession
0001493152-21-005103
Insider Transaction Report
Form 4
Levine Mitchell S
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-02-25$5.34/sh+255,000$1,361,700→ 255,000 totalExercise: $5.34Exp: 2031-02-24→ Common Stock (255,000 underlying)
Footnotes (1)
- [F1]Vesting: Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an employee on the applicable vesting date.
Documents
Issuer
OncoCyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001383492
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:32 PM ET
- Size
- 5.6 KB